IMNM - Immunome  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $28.45. This is a potential upside of $14.16 (99.09%) from yesterday's end of day stock price of $14.29.

Immunome 's activity chart (see below) currently has 9 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.67% with an average time for these price targets to be met of 123.8 days.

Highest price target for IMNM is $33, Lowest price target is $21, average price target is $27.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 20-Mar-2025. First documented stock forecast 27-Oct-2020.

Best performing analysts who are covering IMNM - Immunome :

Matthew Barcus Geulah Livshits David Nierengarten Brian Cheng Biren Amin

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$33

$21.41 (184.73%)

$33

6 months 19 days ago
(20-Mar-2025)

2/6 (33.33%)

$24.34 (281.06%)

14

Buy

$21

$9.41 (81.19%)

$23

10 months 25 days ago
(14-Nov-2024)

0/3 (0%)

$9.86 (88.51%)

Buy

$9

$-3.38 (-27.30%)

$16

3 years 4 months 26 days ago
(13-May-2022)

2/2 (100%)

$6.76 (301.79%)

543

Buy

$33

$20.62 (166.56%)

$35

3 years 8 months 28 days ago
(11-Jan-2022)

0/2 (0%)

$21.36 (183.51%)

Buy

$21

$8.62 (69.63%)

$18

4 years 1 months 19 days ago
(20-Aug-2021)

2/2 (100%)

$8.5 (68.00%)

62

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMNM (Immunome ) average time for price targets to be met?

On average it took 123.8 days on average for the stock forecasts to be realized with a an average price target met ratio 46.67

Which analyst has the current highest performing score on IMNM (Immunome ) with a proven track record?

MATTHEW BARCUS

Which analyst has the current lower performing score on IMNM (Immunome ) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on IMNM (Immunome )?

Matthew Barcus has 7 price targets and 4 ratings on IMNM

Which analyst is the currently most bullish on IMNM (Immunome )?

David Nierengarten with highest potential upside - $21.41

Which analyst is the currently most reserved on IMNM (Immunome )?

Matthew Barcus with lowest potential downside - -$3.38

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?